IL4 and neoplasm: Other studies have demonstrated that pharmacologic inhibition of Axl decreases IL-4 expression in the tumor [55,84], which promotes tumor progression and metastasis through mediating proliferation and survival of lymphocytes, and macrophage polarization towards the M2-like phenotype [85].